Press Releases
Company News
View Summary Medivation Announces Participation in 28th Annual J.P. Morgan Healthcare Conference
Jan 4, 2010
PDF 7.9 KB Add to Briefcase
View Summary Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Dec 17, 2009
PDF 10.9 KB Add to Briefcase
View Summary Medivation to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
Nov 11, 2009
PDF 7.9 KB Add to Briefcase
View Summary Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
Nov 4, 2009
PDF 19.0 KB Add to Briefcase
View Summary Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease
Nov 3, 2009
PDF 15.5 KB Add to Briefcase
View Summary Medivation Announces Third Quarter 2009 Financial Results Teleconference and Webcast on November 4, 2009
Oct 28, 2009
PDF 8.0 KB Add to Briefcase
View Summary Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
Oct 27, 2009
PDF 14.5 KB Add to Briefcase
View Summary Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100
Oct 26, 2009
PDF 7.8 KB Add to Briefcase
View Summary Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs
Oct 23, 2009
PDF 8.3 KB Add to Briefcase
View Summary Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
Sep 23, 2009
PDF 11.4 KB Add to Briefcase
View Summary Medivation Announces Participation in Upcoming Conferences
Sep 9, 2009
PDF 7.8 KB Add to Briefcase
View Summary Medivation Reports Second Quarter 2009 Financial Results and Provides Corporate Update
Aug 5, 2009
PDF 18.4 KB Add to Briefcase
View Summary Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease
Jul 30, 2009
PDF 13.3 KB Add to Briefcase
View Summary Medivation Announces Second Quarter 2009 Financial Results Teleconference and Webcast on August 5, 2009
Jul 29, 2009
PDF 7.8 KB Add to Briefcase
  A Safety, Tolerability, and Pharmacokinetic Study of Dimebon (Latrepirdine) in Patients with Alzheimer's Disease Already Receiving Donepezil
Jul 16, 2009
PDF 446.6 KB Add to Briefcase
View Summary Pfizer and Medivation Present Positive Safety and Tolerability Data on Dimebon in Combination With Donepezil at the International Conference on Alzheimer's Disease
Jul 12, 2009
PDF 11.3 KB Add to Briefcase
View Summary Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease
Jun 11, 2009
PDF 10.7 KB Add to Briefcase
View Summary Medivation to Present at 8th Annual Needham Life Sciences Conference
Jun 4, 2009
PDF 7.7 KB Add to Briefcase
View Summary Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
Jun 2, 2009
PDF 12.0 KB Add to Briefcase
View Summary Medivation Announces Pricing of Public Offering
May 27, 2009
PDF 7.7 KB Add to Briefcase
Showing 241-260 of 387 Page: 1 ... 9 10 11 12 13 14 15 16 17 ... 20  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Top